Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELB139 in Panic Disorder
NCT00322803Phase 2Terminated
- Sponsor
- elbion
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of ELB-139 in panic disorder, sponsored by elbion. Started May 2006; status: terminated.
02
Drugs
ELB-139
03
Conditions
panic disorder
Beyond the preview
Go deeper on NCT00322803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00322803.